Harvard Bioscience (HBIO) EBITDA Margin Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 473.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1,105.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 800.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -71.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -1,411.00 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -1,216.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -51.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -284.00 |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -1,149.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,149.00 |
| Dec 31, 2025 | 14,548.00 |
| Sep 30, 2025 | 1,493.00 |
| Jun 30, 2025 | -1,769.00 |
| Mar 31, 2025 | -20,478.00 |
| Dec 31, 2024 | 1,022.00 |
| Sep 30, 2024 | -1,038.00 |
| Jun 30, 2024 | -916.00 |
| Mar 31, 2024 | -841.00 |
| Dec 31, 2023 | -1,087.00 |
| Sep 30, 2023 | -631.00 |
| Jun 30, 2023 | 653.00 |
| Mar 31, 2023 | 3,207.00 |
| Dec 31, 2022 | 1,073.00 |
| Sep 30, 2022 | 118.00 |
| Jun 30, 2022 | 1,613.00 |
| Mar 31, 2022 | -1,430.00 |
| Dec 31, 2021 | -1.00 |
| Sep 30, 2021 | 73.00 |
| Jun 30, 2021 | 1,345.00 |